Cite

    Gabriele Valentini et al.. “Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study.” Annals of the rheumatic diseases, vol. 78, no. 11, 2019, pp. 1576–1582. http://access.bl.uk/ark:/81055/vdc_100175501520.0x000062